bioengineered tissue

Tissue and tissue scaffolding—polymers with a particular shape—created by manipulating the cells’ core biology to treat injuries to musculoskeletal tissues; it is thought that bioengineered tissue may have potentital to treat defects of cartilage and bone in the future

bioengineered tissue

Implantation surgery Any tissue created by the techniques of cell biology–eg biochemistry and tissue culture, and materials science, which replaces failed or failing tissue. See Biomaterial.
References in periodicals archive ?
The idea of replacing a heart valve was a novel concept, and it helped set the stage for the development of bioengineered tissue heart valves and more recent approaches to delivering bioengineered aortic valves through a catheter.
Macchiarini hopes of using transplants of bioengineered tissue to replace parts of the brain tissues damaged by gunshots, concussions etc.
In this indication, bioengineered tissue and cell therapy products are presumably among the very few methods that could achieve sustained healing.
Bioengineered tissue substitutes and negative pressure therapy systems will command the fastest growth opportunities among other wound management products.
In particular, it can be difficult to identify corneal stem cells and ensure that enough of them are present in the bioengineered tissue to repopulate the ocular surface.
New polymer and bioengineered tissue sealants are decreasing the length of many surgical procedures and are promoting the faster recovery of postoperative patients.
It is the first complex bioengineered tissue part built without synthetic components.
Prefilled staplers; bioengineered tissue adhesives and sealants; collagen, foam and alginate dressings; and growth factor healing agents will see the fastest growth among disposable wound management supplies based on performance and infection prevention benefits in surgery and the treatment of injuries.
The study is designed to provide drug company decision makers, product developers, tissue engineers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for bioengineered tissue repair and wound care.
Additionally, the company's development pipeline includes a next-generation bioengineered tissue product, which is in clinical trials.
By assessing the growth, morphological development, and functional capacity of the bioengineered tissue the researchers demonstrated its ability to beat in response to electrical stimulation and to form vascular networks, ensuring an adequate blood supply.
Four of these products - FortaPerm (TM) bioengineered tissue support, FortaGen(TM) bioengineered tissue repair, PuraPly(TM) bioengineered wound management, and Cuff Patch(TM) soft tissue reinforcement- are already FDA-cleared for marketing and are being used by a number of leading medical institutions.